These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30228349)

  • 21. Androgen receptor promotes the oncogenic function of overexpressed Jagged1 in prostate cancer by enhancing cyclin B1 expression via Akt phosphorylation.
    Yu Y; Zhang Y; Guan W; Huang T; Kang J; Sheng X; Qi J
    Mol Cancer Res; 2014 Jun; 12(6):830-42. PubMed ID: 24574517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. INPP4B is an oncogenic regulator in human colon cancer.
    Guo ST; Chi MN; Yang RH; Guo XY; Zan LK; Wang CY; Xi YF; Jin L; Croft A; Tseng HY; Yan XG; Farrelly M; Wang FH; Lai F; Wang JF; Li YP; Ackland S; Scott R; Agoulnik IU; Hondermarck H; Thorne RF; Liu T; Zhang XD; Jiang CC
    Oncogene; 2016 Jun; 35(23):3049-61. PubMed ID: 26411369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of inositol polyphosphate 4-phosphatase type II as a novel tumor resistance biomarker in human laryngeal cancer HEp-2 cells.
    Kim JS; Yun HS; Um HD; Park JK; Lee KH; Kang CM; Lee SJ; Hwang SG
    Cancer Biol Ther; 2012 Nov; 13(13):1307-18. PubMed ID: 22895072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.
    Xin L; Teitell MA; Lawson DA; Kwon A; Mellinghoff IK; Witte ON
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7789-94. PubMed ID: 16682621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway.
    Chen Y; Sun Z; Qi M; Wang X; Zhang W; Chen C; Liu J; Zhao W
    J Cell Mol Med; 2018 May; 22(5):2935-2943. PubMed ID: 29516642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytosolic phospholipase A2α sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells.
    Hua S; Yao M; Vignarajan S; Witting P; Hejazi L; Gong Z; Teng Y; Niknami M; Assinder S; Richardson D; Dong Q
    Biochim Biophys Acta; 2013 Jun; 1831(6):1146-57. PubMed ID: 23500889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells.
    Min JW; Kim KI; Kim HA; Kim EK; Noh WC; Jeon HB; Cho DH; Oh JS; Park IC; Hwang SG; Kim JS
    Biochem Biophys Res Commun; 2013 Oct; 440(1):137-42. PubMed ID: 24051093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
    Chen H; Luo Q; Li H
    Tumour Biol; 2017 Mar; 39(3):1010428317695941. PubMed ID: 28345464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.
    Chen Y; Chi P; Rockowitz S; Iaquinta PJ; Shamu T; Shukla S; Gao D; Sirota I; Carver BS; Wongvipat J; Scher HI; Zheng D; Sawyers CL
    Nat Med; 2013 Aug; 19(8):1023-9. PubMed ID: 23817021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphoinositide signaling in cancer: INPP4B Akt(s) out.
    Woolley JF; Dzneladze I; Salmena L
    Trends Mol Med; 2015 Sep; 21(9):530-2. PubMed ID: 26150301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INPP4B: the new kid on the PI3K block.
    Agoulnik IU; Hodgson MC; Bowden WA; Ittmann MM
    Oncotarget; 2011 Apr; 2(4):321-8. PubMed ID: 21487159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms.
    Perez-Lorenzo R; Gill KZ; Shen CH; Zhao FX; Zheng B; Schulze HJ; Silvers DN; Brunner G; Horst BA
    J Invest Dermatol; 2014 May; 134(5):1359-1368. PubMed ID: 24288008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
    Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
    Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
    Gewinner C; Wang ZC; Richardson A; Teruya-Feldstein J; Etemadmoghadam D; Bowtell D; Barretina J; Lin WM; Rameh L; Salmena L; Pandolfi PP; Cantley LC
    Cancer Cell; 2009 Aug; 16(2):115-25. PubMed ID: 19647222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.
    Kofuji S; Kimura H; Nakanishi H; Nanjo H; Takasuga S; Liu H; Eguchi S; Nakamura R; Itoh R; Ueno N; Asanuma K; Huang M; Koizumi A; Habuchi T; Yamazaki M; Suzuki A; Sasaki J; Sasaki T
    Cancer Discov; 2015 Jul; 5(7):730-9. PubMed ID: 25883023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in
    Yan Y; An J; Yang Y; Wu D; Bai Y; Cao W; Ma L; Chen J; Yu Z; He Y; Jin X; Pan Y; Ma T; Wang S; Hou X; Weroha SJ; Karnes RJ; Zhang J; Westendorf JJ; Wang L; Chen Y; Xu W; Zhu R; Wang D; Huang H
    EMBO Mol Med; 2018 Apr; 10(4):. PubMed ID: 29523594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. INPP4B protects from metabolic syndrome and associated disorders.
    Zhang M; Ceyhan Y; Kaftanovskaya EM; Vasquez JL; Vacher J; Knop FK; Nathanson L; Agoulnik AI; Ittmann MM; Agoulnik IU
    Commun Biol; 2021 Mar; 4(1):416. PubMed ID: 33772116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of Inositol Polyphosphate 4-Phosphatase Type II Expression in Colorectal Carcinoma.
    Sung JY; Na K; Kim HS
    Anticancer Res; 2017 Oct; 37(10):5525-5531. PubMed ID: 28982866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonism between PTEN/MMAC1/TEP-1 and androgen receptor in growth and apoptosis of prostatic cancer cells.
    Li P; Nicosia SV; Bai W
    J Biol Chem; 2001 Jun; 276(23):20444-50. PubMed ID: 11278645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of EZH2 Expression by INPP4B in Normal Prostate and Primary Prostate Cancer.
    Zhang M; Ceyhan Y; Mei S; Hirz T; Sykes DB; Agoulnik IU
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.